Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.
Consolidated Financial Results
for the Nine Months Ended December 31, 2024
(under Japanese GAAP)
February 5, 2025
Company name: | Sanyo Chemical Industries, Ltd. |
Listing: | Tokyo Stock Exchange |
Securities code: | 4471 |
URL: | https://www.sanyo-chemical.co.jp/ |
Representative: | Akinori Higuchi, President & CEO |
Inquiries: | Kenichi Nishimura, Director & Executive Officer, General Manager of Administration |
Division | |
TEL: | +81-75-541-4312 |
Scheduled date to commence dividend payments: | – |
Preparation of supplementary material on financial results: | None |
Holding of financial results presentation meeting: | None |
(Figures are rounded down to the nearest million yen) |
1. Consolidated financial results for the first nine months of the fiscal year ending March 31, 2025 (from April 1, 2024 to December 31, 2024)
(1) Consolidated operating results (cumulative) | (% indicates year-on-year changes) | |||||||||||||||
Net sales | Operating profit | Ordinary profit | Profit attributable to | |||||||||||||
owners of parent | ||||||||||||||||
Nine months ended | Millions of yen | % | Millions of yen | % | Millions of yen | % | Millions of yen | % | ||||||||
December 31, 2024 | 111,108 | (9.0) | 6,872 | 62.9 | 8,588 | 24.8 | 3,640 | 22.1 | ||||||||
December 31, 2023 | 122,132 | (9.0) | 4,217 | (35.0) | 6,884 | (22.6) | 2,980 | (52.6) | ||||||||
Note: | Comprehensive income: Nine months ended December 31, 2024 | ¥1,681 million [(56.8)%] | ||||||||||||||
Nine months ended December 31, 2023 | ¥3,892 million [(40.7)%] | |||||||||||||||
Basic earnings per share | Diluted earnings per | |||||||||||||||
share | ||||||||||||||||
Nine months ended | Yen | Yen | ||||||||||||||
December 31, 2024 | 164.70 | – | ||||||||||||||
December 31, 2023 | 135.00 | – | ||||||||||||||
(2) Consolidated financial position | ||||||||||||||||
Total assets | Net assets | Equity ratio | Net assets per share | |||||||||||||
As of | Millions of yen | Millions of yen | % | Yen | ||||||||||||
December 31, 2024 | 184,295 | 139,256 | 74.1 | 6,170.93 | ||||||||||||
March 31, 2024 | 205,818 | 141,577 | 67.6 | 6,295.31 | ||||||||||||
Reference: | Equity: | As of December 31, 2024 | ¥136,514 million | |||||||||||||
As of March 31, 2024 | ¥139,037 million |
2. Cash dividends
Cash dividends per share | |||||
1Q (as of June 30) | 2Q (as of Sept. 30) | 3Q (as of Dec. 31) | 4Q (as of Mar. 31) | Total | |
Yen | Yen | Yen | Yen | Yen | |
Fiscal year ended | – | 85.00 | – | 85.00 | 170.00 |
March 31, 2024 | |||||
Fiscal year ending | – | 85.00 | – | ||
March 31, 2025 | |||||
Fiscal year ending | |||||
March 31, 2025 | 85.00 | 170.00 | |||
(Forecast) | |||||
Note: Revisions of the latest forecasts for cash dividends announced: None |
3. Consolidated earnings forecasts for the fiscal year ending March 31, 2025 (from April 1, 2024 to March 31, 2025)
(% indicates year-on-year changes) | ||||||||||||||
Profit attributable to | Basic | |||||||||||||
Net sales | Operating profit | Ordinary profit | earnings | |||||||||||
owners of parent | ||||||||||||||
per share | ||||||||||||||
Fiscal year ending | Millions of yen | % | Millions of yen | % | Millions of yen | % | Millions of yen | % | Yen | |||||
145,000 | (9.1) | 9,000 | 84.2 | 10,000 | 22.1 | 4,000 | – | 180.92 | ||||||
March 31, 2025 | ||||||||||||||
Note: Revisions of the latest forecasts for earnings announced: None |
- Notes
- Significant changes in subsidiaries during the nine months ended December 31, 2024 (changes in specific subsidiaries resulting in the change in scope of consolidation): Yes
Excluded: 1 company (San-Dia Polymers (Nantong) Co., Ltd.)
Note: See page 10, “2. Quarterly consolidated financial statements and significant notes thereto, (4) Notes to quarterly consolidated financial statements, Significant changes in subsidiaries during the period” for more information. - Application of special accounting methods for the preparation of quarterly consolidated financial statements: Yes
Note: See page 10, “2. Quarterly consolidated financial statements and significant notes thereto, (4) Notes to quarterly consolidated financial statements, Application of special accounting methods for the preparation of quarterly consolidated financial statements” for more information. - Changes in accounting policies, accounting estimates, and restatements
a. | Changes in accounting policies associated with revised accounting standards, etc.: | Yes |
b. | Changes in accounting policies other than a. above: | None |
c. | Changes in accounting estimates: | Yes |
d. | Restatements: | None |
Note: See page 10, “2. Quarterly consolidated financial statements and significant notes thereto, (4) Notes to quarterly consolidated financial statements, Changes in accounting policies and Changes in accounting estimates” for more information.
- Number of shares issued (common stock)
a. Number of shares issued at the end of the period (including treasury shares)
As of December 31, 2024
As of March 31, 2024
23,534,752 shares
23,534,752 shares
b. Number of treasury shares at the end of the period
As of December 31, 2024
As of March 31, 2024
1,412,502 shares
1,448,955 shares
- Average number of shares outstanding during the period (cumulative from the beginning of the fiscal year)
For the nine months ended December 31, 2024
For the nine months ended December 31, 2023
22,105,143 shares
22,080,516 shares
Note: Shares of Sanyo Chemical Industries, Ltd. (the “Company”) owned by the trust whose beneficiaries are directors, etc. of the Company are included in the treasury shares that are excluded in calculating the number of treasury shares at the end of the period and the average number of shares outstanding during the period.
- Review of the Japanese-language originals of the attached quarterly consolidated financial statements by certified public accountants or an audit corporation: None
- Appropriate use of earnings forecasts and other special items
The forward-looking statements, including earnings forecasts, contained in these materials are based on information currently available to the Company and on certain assumptions deemed to be reasonable. Consequently, any statements herein do not constitute assurances regarding actual results by the Company. Actual earnings may differ significantly due to various factors. See page 4, “1. Qualitative information regarding financial results for the nine months ended December 31, 2024, (3) Information concerning future forecast such as consolidated earnings forecasts” for more information regarding the circumstances behind the assumptions used in earnings forecasts and matters to be noted when relying on earnings forecasts.
Attached Material Index | ||
1. Qualitative information regarding financial results for the nine months ended December 31, 2024 | .... 2 | |
(1) | Financial position and operating results | 2 |
(2) | Cash flows | 4 |
(3) | Information concerning future forecast such as consolidated earnings forecasts | 4 |
2. Quarterly consolidated financial statements and significant notes thereto | 5 | |
(1) | Consolidated balance sheets | 5 |
(2) | Consolidated statements of income and consolidated statements of comprehensive income | 7 |
Consolidated statements of income (cumulative) | 7 | |
Consolidated statements of comprehensive income (cumulative) | 8 | |
(3) | Consolidated statements of cash flows | 9 |
(4) | Notes to quarterly consolidated financial statements | 10 |
Notes to going concern assumptions | 10 | |
Significant changes in subsidiaries during the period | 10 | |
Notes on significant changes in the amount of shareholders’ equity | 10 | |
Application of special accounting methods for the preparation of quarterly consolidated financial | ||
statements | 10 | |
Changes in accounting policies | 10 | |
Changes in accounting estimates | 10 | |
Consolidated statements of income | 11 | |
Consolidated statements of cash flows | 12 | |
Notes on segment information, etc | 13 | |
3. Supplementary information | 16 |
- 1 -
1. Qualitative information regarding financial results for the nine months ended December 31, 2024
- Financial position and operating results
During the first nine months (April 1, 2024 to December 31, 2024) of the fiscal year ending March 31, 2025, Japanese economy showed a gradual recovery against a backdrop of an improvement in the employment and income environment. In the global economy, while the U.S. economy has remained resilient and the European economy showed a recovery trend, China’s economic recovery has lagged due to factors such as deteriorating real estate market conditions. In addition, resource and energy prices remained high and inflationary against the backdrop of the prolonged situation in Russia and Ukraine and emergence of the geopolitical risk over the Middle East, making the outlook uncertain.
In the chemical industry, despite wild fluctuations the trend of the forex market was one of yen depreciation, as there was not only a limited tightening of the gap between Japanese and U.S. interest rates but also an expectation that the pace of interest rate cuts would slow, given the risk that the policies of the new administration would reignite inflation. Furthermore, oil prices dropped amid concerns about the future economic outlook in China with rising geopolitical risk over the Middle East on one hand. As such, the business environment has been unpredictable.
Under these circumstances, net sales for the period under review decreased by 9.0% year on year to
¥111,108 million primarily due to the impact of withdrawal from the superabsorbent polymer business. In term of profit, operating profit was ¥6,872 million (an increase of 62.9% year on year), ordinary profit was ¥8,588 million (an increase of 24.8% year on year), and profit attributable to owners of parent was ¥3,640 million (an increase of 22.1% year on year), mainly due to an improvement in profitability associated with the abovementioned business withdrawal, as well as favorable conditions in the advanced semiconductor field.
- Business performance
(Millions of yen) | ||||||||
Nine months | Nine months | |||||||
ended | ended | Change | FY2023 | |||||
December 31, | December 31, | |||||||
2023 | 2024 | |||||||
(Amount) | (Change) | |||||||
Net sales | 122,132 | 111,108 | (11,023) | (9.0)% | 159,510 | |||
Operating profit | 4,217 | 6,872 | 2,654 | 62.9% | 4,886 | |||
Ordinary profit | 6,884 | 8,588 | 1,704 | 24.8% | 8,186 | |||
Profit attributable to owners | 2,980 | 3,640 | 659 | 22.1% | (8,501) | |||
of parent | ||||||||
Basic earnings per share | ¥135.00 | ¥164.70 | ¥29.70 | 22.0% | ¥(384.99) | |||
ROA (Return on assets*) | 4.5% | 5.9% | – | 1.4 percentage | 4.0% | |||
point | ||||||||
ROE (Return on equity) | 2.7% | 3.5% | – | 0.8 percentage | (6.0)% | |||
point | ||||||||
ROIC (Return on invested | 1.7% | 4.4% | – | 2.7 percentage | 2.4% | |||
capital) | point | |||||||
Currency exchange (US$, | US$=¥143.33 | US$=¥152.64 | ¥9.31 | US$=¥144.59 | ||||
CNY) | CNY=¥19.98 | CNY=¥21.17 | ¥1.19 | CNY=¥20.14 | ||||
Naphtha price in Japan | ¥68,000/kl | ¥76,400/kl | ¥8,400/kl | ¥69,100/kl |
*ROA (Return on assets) is calculated based on ordinary profit.
Note: ROA, ROE and ROIC for the nine months ended December 31, 2023 and 2024 are annualized.
- 2 -
2) Business performance by segment
(Millions of yen) | ||||||||
Nine months ended | Nine months ended | Change | FY2023 | |||||
December 31, 2023 | December 31, 2024 | |||||||
Net sales | Operating | Net sales | Operating | Net sales | Operating | Net sales | Operating | |
profit | profit | profit | profit | |||||
Toiletries and Health | 35,356 | (1,111) | 25,940 | 209 | (9,416) | 1,321 | 45,895 | (1,421) |
Care | ||||||||
Petroleum and | 38,719 | 2,142 | 37,536 | 3,092 | (1,182) | 950 | 50,479 | 2,819 |
Automotives | ||||||||
Plastics and Textiles | 19,176 | 1,895 | 20,432 | 2,256 | 1,255 | 360 | 25,235 | 2,367 |
Information and | 17,113 | 1,652 | 15,888 | 2,086 | (1,224) | 434 | 22,870 | 1,831 |
Electrics/Electronics | ||||||||
Environmental | ||||||||
Protection, Construction | 11,765 | 565 | 11,311 | 40 | (454) | (524) | 15,030 | 539 |
and Others |
In the Toiletries segment, both the domestic and global markets for polyethyleneglycol recovered, resulting in strong sales.
In the Health Care segment, sales declined significantly as a result of withdrawal from the superabsorbent polymer business.
As a result, total net sales in this segment decreased by 26.6% year on year, to ¥25,940 million. Operating profit was ¥209 million (compared to operating loss of ¥1,111 million during the same period of the previous fiscal year).
In the Petroleum segment, a recovery in demand for lubricant additives led to favorable sales.
In the Automotives segment, with automobile production flat, sales were sluggish as a result of raw materials for polyurethane foams used in automobile seats and other applications being weak due to the inflow of low-cost products from overseas, in addition to which there was a decrease in polyurethane beads for interior parts of automobiles to overseas destinations.
As a result, total net sales in this segment decreased by 3.1% year on year, to ¥37,536 million. Operating profit was ¥3,092 million (an increase of 44.4% year on year).
In the Plastics segment, sales performed well because sales of permanent antistatic agents grew due to a recovery in demand, and sales of paint coating agents and additives were also strong.
In the Textiles segment, sales were brisk, despite sluggishness in agents for synthetic leather, due to a sharp increase in sales of spin finish oil used in the manufacturing process of tire cord yarns following a recovery in demand, and a rebound in chemicals for carbon fibers used in wind turbines for wind power generation.
As a result, total net sales in this segment increased by 6.5% year on year, to ¥20,432 million. Operating profit was ¥2,256 million (an increase of 19.0% year on year).
In the Information segment, sales decreased significantly, reflecting weak sales of polymerization toner- related materials, mainly due to the withdrawal from production operations in China, despite a recovery trend in demand for toner resins.
In the Electrics/Electronics segment, sales of electrolyte for aluminum electrolytic capacitors were flat, but materials associated with advanced semiconductors performed strongly, and sales increased.
As a result, total net sales in this segment decreased by 7.2% year on year, to ¥15,888 million. Operating profit was ¥2,086 million (an increase of 26.3% year on year).
In the Environmental Protection segment, sales were weak due to sluggish market conditions for cationic monomer for polymer flocculants.
In the Construction segment, a slump in sales of cement agents was offset by a recovery in sales of raw materials for polyurethane foams used in furniture, insulation agents, and other applications, leading to flat sales.
- 3 -
As a result, total net sales in this segment decreased by 3.9% year on year, to ¥11,311 million. Operating profit was ¥40 million (a decrease of 92.8% year on year).
The Group’s financial position at the end of the period under review was as follows:
Total assets decreased by ¥21,522 million compared with the end of the previous fiscal year, amounting to ¥184,295 million.
Net assets decreased by ¥2,321 million from the end of the previous fiscal year, to ¥139,256 million. Equity ratio rose by 6.5 percentage points from the end of the previous fiscal year, to 74.1%.
- Cash flows
Cash and cash equivalents (“cash”) as of the end of the period under review amounted to ¥16,837 million. This marked a decrease of ¥10,351 million compared with the end of the previous fiscal year.
The cash flow movements during the period under review and the factors influencing them were as follows:
Cash flows from operating activities
Net cash provided by operating activities amounted to ¥9,441 million (compared to ¥14,366 million in net cash provided during the same period of the previous fiscal year). This result was mainly due to the cash inflow from profit before income taxes of ¥6,302 million and depreciation of ¥7,381 million, which outweighed the cash outflow mainly from income taxes paid of ¥2,448 million and payment for business restructuring of ¥4,669 million.
Cash flows from investing activities
Net cash used in investing activities amounted to ¥8,458 million (compared to ¥4,416 million in net cash used during the same period of the previous fiscal year). This was mainly due to purchase of non-current assets of ¥5,342 million, and payments for sale of investments in capital of subsidiaries and associates resulting in change in scope of consolidation of ¥3,589 million.
Cash flows from financing activities
Net cash used in financing activities amounted to ¥11,475 million (compared to ¥4,097 million in net cash used during the same period of the previous fiscal year). This result was mainly due to the cash outflow from net decrease in short-term borrowings of ¥7,007 million and dividends paid of ¥3,748 million. - Information concerning future forecast such as consolidated earnings forecasts
Performance for the nine months ended December 31, 2024 was in line with the forecasts announced on November 12, 2024, and so the Company has left its full-year consolidated earnings forecasts unchanged.
The rates of progress made during the period under review in comparison to the full-year consolidated earnings forecasts announced on November 12, 2024 are shown in the table below.
(Millions of yen) | ||||
Profit attributable | ||||
Net sales | Operating profit | Ordinary profit | to owners of | |
parent | ||||
Consolidated earnings forecasts | 145,000 | 9,000 | 10,000 | 4,000 |
[Progress to forecasts (%)] | [76.6] | [76.4] | [85.9] | [91.0] |
Results for the previous fiscal year | 159,510 | 4,886 | 8,186 | (8,501) |
(Fiscal year ended March 31, 2024) | ||||
- These earnings forecasts were based on information available at the time of announcement. Actual earnings may differ due to various factors occurring in the future.
- 4 -
2. Quarterly consolidated financial statements and significant notes thereto
- Consolidated balance sheets
(Millions of yen) | |||
As of March 31, 2024 | As of December 31, 2024 | ||
Assets | |||
Current assets | |||
Cash and deposits | 27,240 | 16,908 | |
Notes and accounts receivable - trade | 44,967 | 40,864 | |
Electronically recorded monetary claims - operating | 492 | 185 | |
Merchandise and finished goods | 19,842 | 13,591 | |
Semi-finished goods | 5,082 | 5,228 | |
Work in process | 350 | 24 | |
Raw materials and supplies | 5,859 | 4,504 | |
Other | 2,576 | 8,692 | |
Allowance for doubtful accounts | (484) | (479) | |
Total current assets | 105,929 | 89,521 | |
Non-current assets | |||
Property, plant and equipment | |||
Buildings and structures, net | 16,003 | 14,771 | |
Machinery, equipment and vehicles, net | 22,266 | 20,164 | |
Land | 8,869 | 8,948 | |
Construction in progress | 1,936 | 500 | |
Other, net | 2,401 | 1,852 | |
Total property, plant and equipment | 51,477 | 46,237 | |
Intangible assets | |||
Software | 6,348 | 5,387 | |
Other | 1,214 | 958 | |
Total intangible assets | 7,563 | 6,345 | |
Investments and other assets | |||
Investment securities | 30,701 | 32,987 | |
Long-term loans receivable | 3,545 | 2,683 | |
Deferred tax assets | 417 | 235 | |
Retirement benefit asset | 3,672 | 3,729 | |
Other | 2,541 | 2,586 | |
Allowance for doubtful accounts | (30) | (30) | |
Total investments and other assets | 40,848 | 42,191 | |
Total non-current assets | 99,889 | 94,774 | |
Total assets | 205,818 | 184,295 |
- 5 -
(Millions of yen) | ||
As of March 31, 2024 | As of December 31, 2024 | |
Liabilities | ||
Current liabilities | ||
Accounts payable - trade | 23,849 | 20,890 |
Electronically recorded obligations - operating | 4,911 | 4,140 |
Short-term borrowings | 8,682 | 1,906 |
Current portion of long-term borrowings | 505 | 566 |
Accounts payable - other | 8,491 | 3,982 |
Income taxes payable
Provision for bonuses
Provision for bonuses for directors (and other officers)
Electronically recorded obligations - non-operating Other
Total current liabilities
Non-current liabilities
1,384 | 898 |
2,064 | 1,030 |
36 | 61 |
557 | 723 |
3,035 | 2,814 |
53,519 | 37,014 |
Long-term borrowings | 1,516 | 1,517 | |
Deferred tax liabilities | 2,938 | 3,134 | |
Provision for share-based payments | 431 | 338 | |
Retirement benefit liability | 102 | 139 | |
Provision for business restructuring | 4,706 | 2,261 | |
Other | 1,026 | 634 | |
Total non-current liabilities | 10,720 | 8,025 | |
Total liabilities | 64,240 | 45,039 | |
Net assets | |||
Shareholders’ equity | |||
Share capital | 13,051 | 13,051 | |
Capital surplus | 13,270 | 13,289 | |
Retained earnings | 99,488 | 99,357 | |
Treasury shares | (5,675) | (5,525) | |
Total shareholders’ equity | 120,134 | 120,172 | |
Accumulated other comprehensive income | |||
Valuation difference on available-for-sale securities | 11,584 | 13,054 | |
Foreign currency translation adjustment | 5,978 | 2,023 | |
Remeasurements of defined benefit plans | 1,339 | 1,263 | |
Total accumulated other comprehensive income | 18,902 | 16,342 | |
Non-controlling interests | 2,540 | 2,741 | |
Total net assets | 141,577 | 139,256 | |
Total liabilities and net assets | 205,818 | 184,295 |
- 6 -
- Consolidated statements of income and consolidated statements of comprehensive income Consolidated statements of income (cumulative)
(Millions of yen) | ||||
Nine months ended | Nine months ended | |||
December 31, 2023 | December 31, 2024 | |||
Net sales | 122,132 | 111,108 | ||
Cost of sales | 99,625 | 86,239 | ||
Gross profit | 22,506 | 24,869 | ||
Selling, general and administrative expenses | 18,288 | 17,996 | ||
Operating profit | 4,217 | 6,872 | ||
Non-operating income | ||||
Interest income | 126 | 138 | ||
Dividend income | 931 | 1,114 | ||
Rental income from real estate | 106 | 68 | ||
Foreign exchange gains | 1,328 | 76 | ||
Share of profit of entities accounted for using equity | 124 | 721 | ||
method | ||||
Other | 442 | 68 | ||
Total non-operating income | 3,060 | 2,187 | ||
Non-operating expenses | ||||
Interest expenses | 108 | 99 | ||
Rental costs on real estate | 52 | 51 | ||
Other | 232 | 320 | ||
Total non-operating expenses | 394 | 471 | ||
Ordinary profit | 6,884 | 8,588 | ||
Extraordinary income | ||||
Gain on sale of investment securities | 2,030 | 49 | ||
Insurance claim income | – | 39 | ||
Total extraordinary income | 2,030 | 88 | ||
Extraordinary losses | ||||
Loss on retirement of non-current assets | 941 | 465 | ||
Impairment losses | *1 2,971 | *1 | 308 | |
Loss on valuation of investment securities | – | 8 | ||
Business restructuring expenses | – | *2 | 1,574 | |
Other | – | 18 | ||
Total extraordinary losses | 3,913 | 2,374 | ||
Profit before income taxes | 5,001 | 6,302 | ||
Income taxes | 2,261 | 2,106 | ||
Profit | 2,739 | 4,196 | ||
Profit (loss) attributable to non-controlling interests | (241) | 555 | ||
Profit attributable to owners of parent | 2,980 | 3,640 |
- 7 -
